Study Assessing Efficacy of ZARNESTRAâ„¢ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer
The purpose of this study is to evaluate the objective response rate when ZARNESTRA is added to treatment with tamoxifen
Breast Neoplasms
DRUG: Tamoxifen|DRUG: Zarnestra
To evaluate the objective response rate when ZARNESTRA is added to administration of tamoxifen in patients suffering from metastatic or advanced inoperable breast cancer, who are progressing on tamoxifen treatment
To evaluate the time to progression|To evaluate the clinical benefit (response + stable disease at 6 months)|To evaluate the safety of the combination ZARNESTRA and tamoxifen|To evaluate a possible pharmacokinetic interaction between ZARNESTRA and tamoxifen|To evaluate the biological predictive and prognostic factors of a response
The purpose of this study is to evaluate the objective response rate when ZARNESTRA is added to treatment with tamoxifen